Publications by authors named "Laurent Servais"

Claim this Profile
2
2025 for neuromuscular diseases: a year of multiple advances.
Laurent Servais

Lancet Neurol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Newborn Screening-A Long Road From Pilot to Public Policy.
François Boemer, Laurent Servais

JAMA Pediatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-evaluating acceptable risk of death from gene therapy: A threshold study among individuals with Duchenne muscular dystrophy and their caregivers in the US and UK.
Holly Peay, Ryan Fischer, Megan McNiff, Emma Heslop, Anna Pierce, Laurent Servais

Eur J Med Genet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trach and treat: Safety and motor outcomes following onasemnogene abeparvovec in patients with spinal muscular atrophy and tracheostomies in the RESTORE registry.
Yasemin Erbaş, Laurent Servais, Perry B Shieh, Natalie L Goedeker, Megan A Waldrop

J Neuromuscul Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy.
Thomas O Crawford, Laurent Servais, Eugenio Mercuri, Heike Kölbel, Nancy Kuntz

Expert Rev Neurother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment.
Margaux Poleur, Teresa Gidaro, Stéphanie Delstanche, Jean-Marc Gurruchaga, Alexis Tricot, Laurent Servais

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dystrophin isoform deficiency and upper-limb and respiratory function in Duchenne muscular dystrophy.
Mary Chesshyre, Deborah Ridout, Georgia Stimpson, Valeria Ricotti, Silvana De Lucia, Laurent Servais

Dev Med Child Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Newborn Screening for Retinoblastoma: A Belgian Initiative Baby Detect.
Paulina Bartoszek, François Boemer, Kristine Hovhannesyan, Valérie Jacquemin, Flavia Piazzon, Laurent Servais

Int Ophthalmol Clin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Validation of a Genomic Newborn Screening Workflow.
Kristine Hovhannesyan, Laura Helou, Benoit Charloteaux, Valerie Jacquemin, Flavia Piazzon, Laurent Servais

Int J Neonatal Screen· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and caregiver spinal muscular atrophy treatment attribute preferences in Latin America.
Victoria Saenz, Marijana Chlistalla, Nayara Carlos, Claudia Castiglioni, Maria Soledad Monges, Laurent Servais

J Neuromuscul Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Dystrophin Isoform Deficiency on Motor Development in Duchenne Muscular Dystrophy.
Mary Chesshyre, Deborah Ridout, Georgia Stimpson, Laurent Servais, Giovanni Baranello

Ann Clin Transl Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial.
Thomas O Crawford, Laurent Servais, Eugenio Mercuri, Heike Kölbel, Nancy Kuntz

Lancet Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study.
Perry B Shieh, Wendy Hughes, Marie Wood, Alan H Beggs, Michael W Lawlor, Laurent Servais

Ther Adv Rare Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee.
Maryam Oskoui, Tracie Anne Caller, Julie Parsons, Laurent Servais, Russell J Butterfield

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risdiplam in Presymptomatic Spinal Muscular Atrophy.
Richard S Finkel, Laurent Servais, Dmitry Vlodavets, Edmar Zanoteli, Maria Mazurkiewicz-Bełdzińska

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological report and diagnostic approach used in the neuromuscular population of Liege, Belgium.
Charlotte Mouraux, Tamara Dangouloff, Margaux Poleur, Laurane Mackels, Laura Vanden Brande, Laurent Servais

Orphanet J Rare Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven consideration of genetic disorders for global genomic newborn screening programs.
Thomas Minten, Sarah Bick, Sophia Adelson, Nils Gehlenborg, Laura M Amendola, Laurent Servais

Genet Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newborn screening for spinal muscular atrophy in Ukraine: from pilot project to national programme.
Nataliia Olkhovych, Nataliia Samonenko, Tetiana Shkliarska, Serena Hill, Olena Grechanina, Laurent Servais

Lancet Reg Health Eur· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee.
Maryam Oskoui, Tracie Anne Caller, Julie A Parsons, Laurent Servais, Russell J Butterfield

Neurology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review on motor outcome measures in congenital myopathy.
Matthew Woods, Gemma Fisher, Sarah Johnson, Charlotte Lilien, Laurent Servais

Neuromuscul Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prenatal treatment of spinal muscular atrophy.
Laurent Servais

Mol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy approval for Duchenne muscular dystrophy: a European perspective.
Hannah Jolly, Annemieke Aartsma-Rus, Enrico Bertini, Liesbeth De Waele, Jana Haberlova, Laurent Servais

Lancet· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world analysis of the impact of X-linked myotubular myopathy on caregivers in the United States.
Tina Duong, Tmirah Haselkorn, Beckley Miller, Julie Coats, Ivar Jensen, Laurent Servais

Orphanet J Rare Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-linked myotubular myopathy: an untreated treatable disease.
Cristina Martin, Laurent Servais

Expert Opin Biol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal muscular atrophy in the UK: the human toll of slow decisions.
Laurent Servais, Tamara Dangouloff, Francesco Muntoni, Mariacristina Scoto, Giovanni Baranello

Lancet· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis